Cubist Systematic Strategies, LLC Cara Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$17.3 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $206,216 - $411,198	-123,483 Reduced 66.89%	61,121 $102,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $522,429 - $911,943	184,604 New	184,604 $522,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $2.05 Million - $3.8 Million	274,869 Added 9107.65%	277,887 $2.54 Million
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $1.05 Million - $1.34 Million	-106,067 Reduced 97.23%	3,018 $37,000
Q4 2021 Feb 14, 2022	BUY	$11.99 - $18.14 $1.08 Million - $1.64 Million	90,332 Added 481.69%	109,085 $1.33 Million

Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $216,597 - $301,173	18,753 New	18,753 $290,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $694,703 - $1.64 Million	-56,115 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $228,702 - $329,470	15,176 Added 37.07%	56,115 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $359,810 - $457,117	-28,287 Reduced 40.86%	40,939 $619,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $248,169 - $360,389	20,111 Added 40.95%	69,226 $881,000
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $480,793 - $672,490	38,805 Added 376.38%	49,115 $840,000
Q1 2020 May 15, 2020	SELL	$9.12 - $17.78 $437,075 - $852,106	-47,925 Reduced 82.3%	10,310 $136,000
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $733,568 - $1.18 Million	45,535 Added 358.54%	58,235 $938,000
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $232,156 - $341,757	12,700 New	12,700 $232,000
Q2 2019 Aug 14, 2019	SELL	$17.68 - $21.57 $37,216 - $45,404	-2,105 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$14.41 - $19.64 $546,744 - $745,180	-37,942 Reduced 94.74%	2,105 $41,000
Q4 2018 Feb 14, 2019	BUY	$12.45 - $23.47 $498,585 - $939,903	40,047 New	40,047 $521,000

Others Institutions Holding CARA

# of Institutions

102

Shares Held

21.5M

Call Options Held

50K

Put Options Held

Black Rock Inc. New York, NY

3.42M
Shares

$1.13 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.48M
Shares

$818,815
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.82M
Shares

$598,969
0.03% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$561,696
0.15% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$513,562
0.01% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $17.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account